Table 1.
Comparison of the demographic characteristics for first-episode schizophrenia and healthy control
FESZ (Mean±SD) (n=17) |
HC (Mean±SD) (n=17) |
t | df | p | |
---|---|---|---|---|---|
Age at scan(years) | 21.5±4.8 | 23.1±3.5 | −1.11 | 32 | 0.27 |
Gender(Male/Female) | 13/4 | 12/5 | 1.00a | ||
Education(years) | 13.7±3.1 | 14.1±1.7 | −0.50 | 23.7 | 0.62 |
Parental SES | 2.3±1.5 | 1.7±0.7 | 1.25 | 20.3 | 0.23 |
Current estimated Iintellectual ability |
114.1±11.7 | 118.9±10.4 | −1.1 | 25 | 0.27 |
Ethnicity (H/N/U)b | 4/13/0 | 1/15/1 | |||
Asian East Southwest |
1 | ||||
Asian, Western | 9 | ||||
Black or African American |
1 | 4 | |||
White | 14 | 3 | |||
Other | 1 | 16 | |||
Medication duration (months)c |
4.56±3.10 | ||||
Medication dose (mg) d | 393.3 ±358.2 | ||||
WCSTe categories completed |
3.2±1.7 | 5.4±1.4 | −3.4 | 23 | 0.02 |
FESZ, first-episode schizophrenia; HC, healthy control; SES; socioeconomic status. Current iIntellectual ability was estimated with 2 subtests from the measured by WASI or WAIS-III IQ
Fisher’s exact test.
Ethnicity: H=Hispanic or Latino; N=Not Hispanic or Latino; U=Unknown
Antipsychotic medication duration of all patients
Antipsychotic medication dose of all patients equivalent to chloropromazine at the time of scan.
WCST: the Wisconsin Card Sorting Test